New Weight-Loss drug MD-18 enters early human safety testing
Disease control
Terminated
This early-stage trial is testing a new drug called MD-18 in healthy adults who are overweight or obese. The main goal is to check if the drug is safe and how the body processes it. About 54 participants will receive either MD-18 or a placebo by injection. The study is currently …
Phase: PHASE1 • Sponsor: Cohen Global, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC